These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22342361)

  • 1. Anticoagulants affect matrix metalloproteinase 9 levels in blood samples of stroke patients and healthy controls.
    Rababah M; Worthmann H; Deb M; Tryc AB; Ma YT; El Bendary OM; Hecker H; Goldbecker A; Heeren M; Brand K; Weissenborn K; Lichtinghagen R
    Clin Biochem; 2012 Apr; 45(6):483-9. PubMed ID: 22342361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of anticoagulants on the activity of gelatinases.
    Castellazzi M; Tamborino C; Fainardi E; Manfrinato MC; Granieri E; Dallocchio F; Bellini T
    Clin Biochem; 2007 Nov; 40(16-17):1272-6. PubMed ID: 17904541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma.
    Gerlach RF; Demacq C; Jung K; Tanus-Santos JE
    Clin Biochem; 2007 Jan; 40(1-2):119-23. PubMed ID: 17150202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
    Xu XM; Sun TY; Lin JB; Zhang HS
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of blood sampling procedure on plasma concentrations of matrix metalloproteinases and their tissue inhibitors.
    Rossignol P; Cambillau M; Bissery A; Mouradian D; Benetos A; Michel JB; Plouin PF; Chatellier G; Jacob MP
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):464-9. PubMed ID: 18307742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood.
    Mannello F; Jung K; Tonti GA; Canestrari F
    Clin Biochem; 2008 Dec; 41(18):1466-73. PubMed ID: 18926810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities.
    Gerlach RF; Uzuelli JA; Souza-Tarla CD; Tanus-Santos JE
    Anal Biochem; 2005 Sep; 344(1):147-9. PubMed ID: 15950912
    [No Abstract]   [Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 contributes to the increase of tau protein in serum during acute ischemic stroke.
    Kurzepa J; Bielewicz J; Grabarska A; Stelmasiak Z; Stryjecka-Zimmer M; Bartosik-Psujek H
    J Clin Neurosci; 2010 Aug; 17(8):997-9. PubMed ID: 20627731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
    Bauvois B; Mothu N; Nguyen J; Nguyen-Khoa T; Nöel LH; Jungers P
    Nephrol Dial Transplant; 2007 Apr; 22(4):1115-22. PubMed ID: 17205957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
    Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
    Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma matrix metalloproteinase-9 levels in patients with acute ischemic stroke.
    Cojocarui IM; Cojocaru M; Sapira V; Socoliuc G; Hertea C; Paveliu S
    Rom J Intern Med; 2012; 50(2):155-8. PubMed ID: 23326959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation, gene-expression and circulating levels of matrix metalloproteinase-9 in patients with stable coronary artery disease.
    Opstad TB; Pettersen AA; Weiss TW; Akra S; Øvstebø R; Arnesen H; Seljeflot I
    Clin Chim Acta; 2012 Jan; 413(1-2):113-20. PubMed ID: 21963461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of Bushen qiangdu decoction on MMP-9 and TIMP-1 produced by peripheral blood mononuclear cells in patients with ankylosing spondylitis].
    Zhang YZ; Yan XP; Ye LY; Zhang WJ; Lou JN
    Zhongguo Gu Shang; 2011 May; 24(5):387-91. PubMed ID: 21688534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of peripheral blood mononuclear cells and extracellular matrix and inflammatory gene profile in acute myocardial infarction.
    Fang L; Du XJ; Gao XM; Dart AM
    Clin Sci (Lond); 2010 May; 119(4):175-83. PubMed ID: 20388121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase 9 mRNA: an early prognostic marker for patients with acute stroke.
    Graham CA; Chan RW; Chan DY; Chan CP; Wong LK; Rainer TH
    Clin Biochem; 2012 Mar; 45(4-5):352-5. PubMed ID: 22200563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices.
    Mannello F; Tanus-Santos JE; Meschiari CA; Tonti GA
    Anal Biochem; 2008 Mar; 374(1):56-63. PubMed ID: 18082127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis.
    Hoheisel G; Sack U; Hui DS; Huse K; Chan KS; Chan KK; Hartwig K; Schuster E; Scholz GH; Schauer J
    Tuberculosis (Edinb); 2001; 81(3):203-9. PubMed ID: 11466032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic expression of matrix metalloproteinase-9 in patients with cerebral arteriovenous malformations.
    Starke RM; Komotar RJ; Hwang BY; Hahn DK; Otten ML; Hickman ZL; Garrett MC; Sisti MB; Lavine SD; Meyers PM; Solomon RA; Connolly ES
    Neurosurgery; 2010 Feb; 66(2):343-8; discussion 348. PubMed ID: 20087134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of matrix metalloproteinase MMP-9 in the plasma and hematoma fluid of intracerebral hemorrhage patients].
    Wu CH; Huang FY; Wang KY; Huang SY; Yang RL; Li HZ; Lei HX; Lin JS; Wang JM; Yan XH
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):174-6. PubMed ID: 18361815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.